VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 134 filers reported holding VIRIDIAN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $727,699 | -32.0% | 47,438 | +5.4% | 0.22% | -33.2% |
| Q2 2023 | $1,070,550 | +15.7% | 45,000 | +23.7% | 0.33% | -13.4% |
| Q1 2023 | $925,533 | +956.2% | 36,381 | +1112.7% | 0.38% | +1428.0% |
| Q4 2022 | $87,630 | -96.2% | 3,000 | -97.6% | 0.02% | -97.4% |
| Q1 2022 | $2,332,000 | -4.7% | 126,136 | +1.9% | 0.96% | -2.7% |
| Q4 2021 | $2,448,000 | +40.3% | 123,806 | +16.7% | 0.99% | +0.5% |
| Q3 2021 | $1,745,000 | +236.2% | 106,078 | +273.5% | 0.99% | +327.3% |
| Q2 2021 | $519,000 | +12.6% | 28,399 | +2.9% | 0.23% | -8.0% |
| Q1 2021 | $461,000 | – | 27,586 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 680,768 | $11,376,000 | 2.18% |
| COMMODORE CAPITAL LP | 185,781 | $3,104,000 | 1.24% |
| Ghost Tree Capital, LLC | 300,000 | $5,013,000 | 1.18% |
| Logos Global Management LP | 550,000 | $9,191,000 | 0.90% |
| Atlas Venture Advisors, Inc. | 209,505 | $3,501,000 | 0.65% |
| BVF INC/IL | 463,504 | $7,745,000 | 0.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 27,586 | $461,000 | 0.25% |
| Fairmount Funds Management LLC | 35,092 | $581,000 | 0.24% |
| Soleus Capital Management, L.P. | 67,685 | $1,131,000 | 0.20% |
| Cormorant Asset Management, LP | 459,144 | $7,672,000 | 0.17% |